Title: Inhibition of monoamine oxidase-B by selegiline reduces cigarette smoke-induced oxidative stress and inflammation in airway epithelial cells.
Journal: Toxicology letters20170215
Title: Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
Journal: Chemico-biological interactions20150325
Title: Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20150201
Title: Deprenyl enhances the teratogenicity of hydroxyurea in organogenesis stage mouse embryos.
Journal: Toxicological sciences : an official journal of the Society of Toxicology20130801
Title: Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro.
Journal: International journal of pharmaceutics20121115
Title: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B.
Journal: Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie20121101
Title: Retention rate of selegiline in early Parkinson's disease: a retrospective survey.
Journal: International journal of clinical practice20121001
Title: Involvement of monoamine oxidase B on models of postoperative and neuropathic pain in mice.
Journal: European journal of pharmacology20120905
Title: Cerebral blood flow and freezing of gait in Parkinson's disease.
Journal: Acta neurologica Scandinavica20120901
Title: Pramipexole-related chronic lower limb oedema in a patient with Parkinson's disease.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia20120901
Title: Modulations of brain amines and dopaminergic behavior by a novel, reversible and selective MAO-B inhibitor.
Journal: Brain research20120827
Title: Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease.
Journal: British journal of clinical pharmacology20120801
Title: Activity-based probes for studying the activity of flavin-dependent oxidases and for the protein target profiling of monoamine oxidase inhibitors.
Journal: Angewandte Chemie (International ed. in English)20120709
Title: AIRE-induced apoptosis is associated with nuclear translocation of stress sensor protein GAPDH.
Journal: Biochemical and biophysical research communications20120622
Title: Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease.
Journal: Neurology20120612
Title: Cerebral ischemia-reperfusion induces GAPDH S-nitrosylation and nuclear translocation.
Journal: Biochemistry. Biokhimiia20120601
Title: Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase.
Journal: European journal of pharmacology20120515
Title: Basic cell physiological activities (cell adhesion, chemotaxis and proliferation) induced by selegiline and its derivatives in Mono Mac 6 human monocytes.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20120501
Title: Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures.
Journal: The Journal of clinical psychiatry20120501
Title: Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20120401
Title: In vitro-in vivo correlation for intrinsic clearance for CP-409,092 and sumatriptan: a case study to predict the in vivo clearance for compounds metabolized by monoamine oxidase.
Journal: Xenobiotica; the fate of foreign compounds in biological systems20120401
Title: In vivo evaluation in cynomolgus monkey brain and metabolism of [¹⁸F]fluorodeprenyl: a new MAO-B pet radioligand.
Journal: Synapse (New York, N.Y.)20120401
Title: 8-Substituted 3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation, and docking studies.
Journal: ChemMedChem20120305
Title: Selegiline transdermal system (STS) as an aid for smoking cessation.
Journal: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco20120301
Title: Induction of adipose-derived stem cell into motoneuron-like cells using selegiline as preinducer.
Journal: Brain research20120227
Title: Tyrosine hydroxylase deficiency in Taiwanese infants.
Journal: Pediatric neurology20120201
Title: The effect of selegiline on total scavenger capacity and liver fat content: a preliminary study in an animal model.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20120101
Title: Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine20120101
Title: Selegiline: a reappraisal of its role in Parkinson disease.
Journal: Clinical neuropharmacology20120101
Title: Deprenyl prevents MPP(+)-induced oxidative damage in PC12 cells by the upregulation of Nrf2-mediated NQO1 expression through the activation of PI3K/Akt and Erk.
Journal: Toxicology20111218
Title: In vivo imaging of astrocytosis in Alzheimer's disease: an ¹¹C-L-deuteriodeprenyl and PIB PET study.
Journal: European journal of nuclear medicine and molecular imaging20111201
Title: PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.
Journal: Experimental neurology20111201
Title: Predicting successful 24-hr quit attempt in a smoking cessation intervention.
Journal: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco20111101
Title: Pharmacoresistant convulsions and visual hallucinations around two weeks after selegiline overdose: a case report.
Journal: Pharmacopsychiatry20111101
Title: Synthesis of three novel fluorine-18 labeled analogues of L-deprenyl for positron emission tomography (PET) studies of monoamine oxidase B (MAO-B).
Journal: Journal of medicinal chemistry20111027
Title: Trans-differentiation of the adipose tissue-derived stem cells into neuron-like cells expressing neurotrophins by selegiline.
Journal: Iranian biomedical journal20111001
Title: Selegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization.
Journal: International journal of pharmaceutics20110920
Title: Effects of selegiline, a monoamine oxidase B inhibitor, on differentiation of P19 embryonal carcinoma stem cells, into neuron-like cells.
Journal: In vitro cellular & developmental biology. Animal20110901
Title: Transdermal delivery of selegiline from alginate-Pluronic composite thermogels.
Journal: International journal of pharmaceutics20110830
Title: CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease.
Journal: Brain research20110823
Title: Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association20110801
Title: MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.
Journal: Bioorganic & medicinal chemistry letters20110715
Title: The relationship between depression and regional cerebral blood flow in Parkinson's disease and the effect of selegiline treatment.
Journal: Acta neurologica Scandinavica20110701
Title: Differences in smoking expectancies in smokers with and without a history of major depression.
Journal: Addictive behaviors20110401
Title: Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times.
Journal: Parkinsonism & related disorders20110301
Title: Expanding phenotype and clinical analysis of tyrosine hydroxylase deficiency.
Journal: Journal of child neurology20110201
Title: Tolerability and efficacy of switching from oral selegiline to Zydis selegiline in patients with Parkinson's disease.
Journal: Parkinsonism & related disorders20110201
Title: MAO inhibitors.
Journal: Cleveland Clinic journal of medicine20110201
Title: The anti-Parkinsonian drug selegiline delays the nucleation phase of α-synuclein aggregation leading to the formation of nontoxic species.
Journal: Journal of molecular biology20110107
Title: Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.
Journal: Neurochemistry international20110101
Title: Selegiline and rasagiline: twins or distant cousins?
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists20110101
Title: Pharmacotherapy for late-life depression.
Journal: The Journal of clinical psychiatry20110101
Title: Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro.
Journal: BMC pharmacology20110101
Title: Elevated [11C]-D-deprenyl uptake in chronic Whiplash Associated Disorder suggests persistent musculoskeletal inflammation.
Journal: PloS one20110101
Title: Serum cholesterol and the progression of Parkinson's disease: results from DATATOP.
Journal: PloS one20110101
Title: The pharmacology of selegiline.
Journal: International review of neurobiology20110101
Title: Selective inhibitors of monoamine oxidase type B and the 'cheese effect'.
Journal: International review of neurobiology20110101
Title: Supplementation of deprenyl attenuates age associated alterations in rat cerebellum.
Journal: Molecular biology reports20101201
Title: Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline.
Journal: Journal of clinical pharmacology20101201
Title: R-deprenyl: pharmacological spectrum of its activity.
Journal: Neurochemical research20101201
Title: MAO inhibitors: risks, benefits, and lore.
Journal: Cleveland Clinic journal of medicine20101201
Title: Ring opening of pymisyl-protected aziridines with organocuprates.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)20101102
Title: Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.
Journal: Journal of drug targeting20101101
Title: Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity.
Journal: Progress in neurobiology20101101
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters20101101
Title: Orthostatic hypotension: a non-motor complication assessment in 82 patients with idiopathic Parkinson's disease in Phramongkutklao Hospital.
Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet20101101
Title: The fabulous neuroprotection of selegiline: memoir and prospectus.
Journal: Journal of child neurology20101001
Title: Clozapine for medication-related pathological gambling in Parkinson disease.
Journal: Movement disorders : official journal of the Movement Disorder Society20100915
Title: Age-related protective effect of deprenyl on changes in the levels of diagnostic marker enzymes and antioxidant defense enzymes activities in cerebellar tissue in Wistar rats.
Journal: Cell stress & chaperones20100901
Title: HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology20100901
Title: Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessation.
Journal: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco20100901
Title: Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy.
Journal: Addiction (Abingdon, England)20100901
Title: [The feasibility of synthetic enhancer substances for preventive nanotherapy].
Journal: Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology20100901
Title: Slowing the decline.
Journal: Nature20100826
Title: Cytoprotective effect of (-)-deprenyl, (-)desmethyl-deprenyl and (-)deprenyl-N-oxide on glutathione depleted A-2058 melanoma cells.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20100601
Title: A novel role for glyceraldehyde-3-phosphate dehydrogenase and monoamine oxidase B cascade in ethanol-induced cellular damage.
Journal: Biological psychiatry20100501
Title: Marked improvement in Segawa syndrome after L-dopa and selegiline treatment.
Journal: Pediatric neurology20100501
Title: [General anaesthesia for neurological diseases].
Journal: Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS20100501
Title: Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo.
Journal: Cellular and molecular neurobiology20100401
Title: Manganese neurotoxic time course is not influenced by L-deprenyl systemic treatment: influence of L-deprenyl in manganese neurotoxic time course.
Journal: Brain research20100304
Title: Selegiline is an efficient and potent inducer for bone marrow stromal cell differentiation into neuronal phenotype.
Journal: Neurological research20100301
Title: A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.
Journal: Drug and alcohol dependence20100301
Title: [On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease].
Journal: Fortschritte der Neurologie-Psychiatrie20100301
Title: Cognitive aspects of congenital learned helplessness and its reversal by the monoamine oxidase (MAO)-B inhibitor deprenyl.
Journal: Neurobiology of learning and memory20100201
Title: (-)-Deprenyl inhibits vascular hyperpermeability after hemorrhagic shock.
Journal: Shock (Augusta, Ga.)20100101
Title: Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.
Journal: Clinical neuropharmacology20100101
Title: Early addition of selegiline to L-Dopa treatment is beneficial for patients with Parkinson disease.
Journal: Clinical neuropharmacology20100101
Title: Frontotemporal dementia and pharmacologic interventions.
Journal: The Journal of neuropsychiatry and clinical neurosciences20100101
Title: Transdermal selegiline in patients receiving electroconvulsive therapy.
Journal: Psychosomatics20100101
Title: Electropharmacograms of rasagiline, its metabolite aminoindan and selegiline in the freely moving rat.
Journal: Neuropsychobiology20100101
Title: Zonisamide attenuates MPTP neurotoxicity in marmosets.
Journal: Journal of pharmacological sciences20100101
Title: A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts.
Journal: Movement disorders : official journal of the Movement Disorder Society20091215
Title: Selegiline and oxidative stress in HIV-associated cognitive impairment.
Journal: Neurology20091208
Title: Acidic vesicles of the endo-exocytic pathways as targets for some anti-monoamine oxidase drugs.
Journal: Metabolic brain disease20091201
Title: [Severe apathy following head injury: improvement with Selegiline treatment].
Journal: Neuro-Chirurgie20091201
Title: [Slowing the age-induced decline of brain function with prophylactic use of (-)-deprenyl (Selegiline, Jumex). Current international view and conclusions 25 years after the Knoll's proposal].
Journal: Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology20091201
Title: Effect of deprenyl on free radical oxidation in rat brain during immobilization stress.
Journal: Bulletin of experimental biology and medicine20091201
Title: Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.
Journal: Neurology20091103
Title: Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson's disease drug, rasagiline compared with selegiline, in the rat midbrain.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20091101
Title: Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease.
Journal: The Cochrane database of systematic reviews20091007
Title: Transdermal permeation of selegiline from hydrogel-membrane drug delivery systems.
Journal: International journal of pharmaceutics20091001
Title: (-)Deprenyl-N-oxide, a (-)deprenyl metabolite, is cytoprotective after hypoxic injury in PC12 cells, or after transient brain ischemia in gerbils.
Journal: Journal of the neurological sciences20090815
Title: Serotonin toxicity caused by moclobemide too soon after paroxetine-selegiline.
Journal: Journal of the Chinese Medical Association : JCMA20090801
Title: Selegiline shortage: Causes and costs of a generic drug shortage.
Journal: Neurology20090721
Title: Selegiline transdermal system: a novel treatment option for major depressive disorder.
Journal: Expert opinion on pharmacotherapy20090701
Title: A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors.
Journal: Bioorganic & medicinal chemistry letters20090615
Title: Teasing apart drug treatments and individual symptoms in narcolepsy.
Journal: Sleep medicine20090601
Title: Short-term erythrosine B-induced inhibition of the brain regional serotonergic activity suppresses motor activity (exploratory behavior) of young adult mammals.
Journal: Pharmacology, biochemistry, and behavior20090601
Title: Involvement of protein trafficking in deprenyl-induced alpha-secretase activity regulation in PC12 cells.
Journal: European journal of pharmacology20090521
Title: Long-term administration of monoamine oxidase inhibitors alters the firing rate and pattern of dopamine neurons in the ventral tegmental area.
Journal: The international journal of neuropsychopharmacology20090501
Title: Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301.
Journal: Clinical pharmacology and therapeutics20090501
Title: Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP.
Journal: Journal of pharmacological sciences20090501
Title: MAO-B inhibitor know-how: back to the pharm.
Journal: Neurology20090414
Title: Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish.
Journal: Journal of neurochemistry20090401
Title: Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis.
Journal: Neurotoxicity research20090401
Title: 'Bad guys' among the antiparkinsonian drugs.
Journal: Psychiatria Danubina20090301
Title: Antioxidant and antiapoptotic activities of deprenyl and estradiol co-administration in aged rat kidney.
Journal: Acta biologica Hungarica20090301
Title: Neuroprotection by rasagiline in thiamine deficient rats.
Journal: Brain research20090223
Title: MPTP and MPP+ target specific aminergic cell populations in larval zebrafish.
Journal: Journal of neurochemistry20090201
Title: [Neuroprotection in Parkinson's disease and other neurodegenerative disorders: preclinical and clinical findings].
Journal: Ideggyogyaszati szemle20090130
Title: A case report of high-dose transdermal selegiline in the treatment of major depressive disorder.
Journal: Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists20090101
Title: Investigation of oral selegiline and rasagiline administration on QT interval in conscious rabbits.
Journal: European review for medical and pharmacological sciences20090101
Title: A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion.
Journal: BMC clinical pharmacology20090101
Title: (-)-Deprenyl inhibits thermal injury-induced apoptotic signaling and hyperpermeability in microvascular endothelial cells.
Journal: Journal of burn care & research : official publication of the American Burn Association20090101
Title: Serum prolactin as a tool for the follow-up of treated DHPR-deficient patients.
Journal: Journal of inherited metabolic disease20081201
Title: Antidepressant activity of curcumin: involvement of serotonin and dopamine system.
Journal: Psychopharmacology20081201
Title: 1-Methyl-4-phenyl-pyridinium ion-induced oxidative stress, c-Jun phosphorylation and DNA fragmentation factor-45 cleavage in SK-N-SH cells are averted by selegiline.
Journal: Neurochemistry international20081201
Title: The effect of short-term administration of (-)-deprenyl and isatin on the expressions of some genes in the mouse brain cortex.
Journal: Medical science monitor : international medical journal of experimental and clinical research20081201
Title: Neural progenitor cells are protected against MPTP by MAO-B inhibitors.
Journal: Neurotoxicology20081101
Title: Orally disintegrating selegiline for the treatment of Parkinson's disease.
Journal: Expert opinion on pharmacotherapy20081101
Title: Protective effects of deprenyl in transient cerebral ischemia in rats.
Journal: The Chinese journal of physiology20081031
Title: Apomorphine offers new insight into dopaminergic neuron vulnerability in mesencephalic cultures.
Journal: Neuropharmacology20081001
Title: Pharmacological treatment in moderate-to-severe Alzheimer's disease.
Journal: Expert opinion on pharmacotherapy20081001
Title: Detection of levorotatory methamphetamine and levorotatory amphetamine in urine after ingestion of an overdose of selegiline.
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan20081001
Title: [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Journal: Fortschritte der Neurologie-Psychiatrie20081001
Title: [Motor symptoms in Parkinson disease].
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke20080925
Title: Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD.
Journal: Neurology20080812
Title: Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35).
Journal: Behavioural brain research20080719
Title: Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration.
Journal: Journal of neurochemistry20080601
Title: Study of high deprenyl dose on the preimplantation embryo development and lymphocyte DNA in rat.
Journal: General physiology and biophysics20080601
Title: Selegiline reduces cisplatin-induced neuronal death in neuroblastoma cells.
Journal: Neurological research20080501
Title: The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B.
Journal: British journal of pharmacology20080501
Title: Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.
Journal: Movement disorders : official journal of the Movement Disorder Society20080415
Title: Selegilin exerts antidepressant-like effects during the forced swim test in adrenocorticotropic hormone-treated rats.
Journal: Journal of pharmacological sciences20080401
Title: Optimization and validation of a dissolution test for selegiline hydrochloride tablets by a novel rapid HPLC assay using a monolithic stationary phase.
Journal: Journal of pharmaceutical and biomedical analysis20080313
Title: Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Journal: Human psychopharmacology20080301
Title: Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and mice.
Journal: The Journal of pharmacology and experimental therapeutics20080301
Title: Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.
Journal: Neurotoxicology20080301
Title: [A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508].
Journal: Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology20080301
Title: [Role of apoptosis in the kidney after reperfusion].
Journal: Orvosi hetilap20080217
Title: Transdermal selegiline: new opportunity for managing depression.
Journal: The Journal of the American Osteopathic Association20080201
Title: [The use of Stalevo in Hungary for patients with Parkinson disease and its effect on the quality of life].
Journal: Ideggyogyaszati szemle20080130
Title: Parallel analysis of stimulants in saliva and urine by gas chromatography/mass spectrometry: perspectives for 'in competition' anti-doping analysis.
Journal: Analytica chimica acta20080114
Title: The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability.
Journal: Journal of affective disorders20080101
Title: Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20080101
Title: Neurobehavioral protection by single dose l-deprenyl against MPTP-induced parkinsonism in common marmosets.
Journal: Psychopharmacology20080101
Title: Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
Journal: Journal of psychiatric practice20080101
Title: Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant.
Journal: Arzneimittel-Forschung20080101
Title: Paradoxical effects of adenosine receptor ligands on hydroxyl radical generation by L-DOPA in the rat striatum.
Journal: Pharmacological reports : PR20080101
Title: Antagonistic effect of low deprenyl dose on the preimplantation embryo development in rat.
Journal: Bratislavske lekarske listy20080101
Title: Possible new antiaging strategies related to neuroendocrine-immune interactions.
Journal: Neuroimmunomodulation20080101
Title: Differential effects of selegiline on glucose synthesis in rabbit kidney-cortex tubules and hepatocytes. In vitro and in vivo studies.
Journal: Chemico-biological interactions20071215
Title: In vitro metabolism of the analgesic bicifadine in the mouse, rat, monkey, and human.
Journal: Drug metabolism and disposition: the biological fate of chemicals20071201
Title: Monoamine oxidase-B inhibition in the treatment of Parkinson's disease.
Journal: Pharmacotherapy20071201
Title: Symptoms of sexual dysfunction in patients treated for major depressive disorder: a meta-analysis comparing selegiline transdermal system and placebo using a patient-rated scale.
Journal: The Journal of clinical psychiatry20071201
Title: Deprenyl treatment attenuates long-term pre- and post-synaptic changes evoked by chronic methamphetamine.
Journal: European journal of pharmacology20071114
Title: Gestational exposure to nicotine and monoamine oxidase inhibitors influences cocaine-induced locomotion in adolescent rats.
Journal: Psychopharmacology20071101
Title: Bystander effects of ionizing radiation can be modulated by signaling amines.
Journal: Environmental research20071001
Title: Pharmacokinetics and absolute bioavailability of selegiline following treatment of healthy subjects with the selegiline transdermal system (6 mg/24 h): a comparison with oral selegiline capsules.
Journal: Journal of clinical pharmacology20071001
Title: Zydis selegiline in the management of Parkinson's disease.
Journal: Expert opinion on pharmacotherapy20071001
Title: A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.
Journal: Neurology20070925
Title: Lost in translation: again, another failed neuroprotection trial.
Journal: Neurology20070925
Title: Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?
Journal: Journal of psychiatry & neuroscience : JPN20070901
Title: Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
Journal: Clinical therapeutics20070901
Title: A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: pharmacological validation with R-(-)-deprenyl.
Journal: Journal of neuroscience methods20070815
Title: Selegiline transdermal system: current awareness and promise.
Journal: Progress in neuro-psychopharmacology & biological psychiatry20070815
Title: Evaluation of the potential for pharmacodynamic and pharmacokinetic drug interactions between selegiline transdermal system and two sympathomimetic agents (pseudoephedrine and phenylpropanolamine) in healthy volunteers.
Journal: Journal of clinical pharmacology20070801
Title: Low plasma uric acid level in Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society20070615
Title: The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates.
Journal: Molecular pharmacology20070601
Title: Antioxidant effects of selegiline in oxidative stress induced by iron neonatal treatment in rats.
Journal: Neurochemical research20070601
Title: Therapeutic advances in narcolepsy.
Journal: Sleep medicine20070601
Title: Treatment-resistant depression: response to low-dose transdermal but not oral selegiline.
Journal: Journal of clinical psychopharmacology20070601
Title: Transdermal selegiline.
Journal: Drugs of today (Barcelona, Spain : 1998)20070601
Title: Rasagiline as a therapy for Parkinson's disease (PD).
Journal: The American journal of geriatric pharmacotherapy20070601
Title: Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for alpha-synuclein fibrils in vitro.
Journal: Journal of neuroscience research20070515
Title: The role of selegiline in the treatment of negative symptoms associated with schizophrenia.
Journal: The Annals of pharmacotherapy20070501
Title: Bacopa monniera prevents from aluminium neurotoxicity in the cerebral cortex of rat brain.
Journal: Journal of ethnopharmacology20070420
Title: Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET.
Journal: Journal of the neurological sciences20070415
Title: Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease.
Journal: Current medical research and opinion20070401
Title: Translating the evidence on atypical depression into clinical practice.
Journal: The Journal of clinical psychiatry20070401
Title: P450 phenotyping of the metabolism of selegiline to desmethylselegiline and methamphetamine.
Journal: Drug metabolism and pharmacokinetics20070401
Title: Involvement of cytochromes P450 2D6, 2B6 and 2C19 in the metabolism of (-)-deprenyl and N-methyl,N-propargylphenylethylamine.
Journal: Drug metabolism letters20070401
Title: Oxygen-glucose deprivation-induced changes in organotypic cultures of the rat hippocampus.
Journal: Ideggyogyaszati szemle20070330
Title: Metabolism of N-methyl, N-propargylphenylethylamine: studies with human liver microsomes and cDNA expressed cytochrome P450 (CYP) enzymes.
Journal: Cellular and molecular neurobiology20070301
Title: Selegiline and blood pressure in patients with Parkinson's disease.
Journal: Acta neurologica Scandinavica20070201
Title: Selegiline transdermal system: an examination of the potential for CYP450-dependent pharmacokinetic interactions with 3 psychotropic medications.
Journal: Journal of clinical pharmacology20070201
Title: Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?
Journal: International psychogeriatrics20070201
Title: Separation of enantiomers of deprenyl with various CDs in CE and the effect of enantiomer migration order on enantiomeric impurity determination of selegiline in active ingredients and tablets.
Journal: Electrophoresis20070201
Title: Psychopharmacology column: why choose selegiline transdermal system for refractory depression?
Journal: Issues in mental health nursing20070201
Title: Management of sexual dysfunction due to antipsychotic drug therapy.
Journal: The Cochrane database of systematic reviews20070124
Title: Improvement of mouse brain mitochondrial function after deprenyl treatment.
Journal: Neuroscience20070119
Title: Mitogen activated protein kinase and protein kinase C activation mediate promotion of sAPPalpha secretion by deprenyl.
Journal: Neurochemistry international20070101
Title: Chronic (-)-deprenyl administration attenuates dendritic developmental impairment induced by early social isolation in the rat.
Journal: Developmental neuroscience20070101
Title: Seligiline transdermal system in depression.
Journal: Expert opinion on pharmacotherapy20070101
Title: Effects of a tyramine-enriched meal on blood pressure response in healthy male volunteers treated with selegiline transdermal system 6 mg/24 hour.
Journal: CNS spectrums20070101
Title: Selegiline transdermal system: in the treatment of major depressive disorder.
Journal: Drugs20070101
Title: The effect of l-deprenyl on tissue mRNA expressions of NOS isoforms and NO levels in an experimental diabetes mellitus model.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20070101
Title: Selegiline transdermal system in major depressive disorder: profile report.
Journal: CNS drugs20070101
Title: Monamine oxidase inhibitors: current and emerging agents for Parkinson disease.
Journal: Clinical neuropharmacology20070101
Title: Suppression of apoptosis and oxidative stress by deprenyl and estradiol in aged rat liver.
Journal: Acta histochemica20070101
Title: Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.
Journal: Drugs & aging20070101
Title: Selegiline orally disintegrating tablets in patients with Parkinson disease and 'wearing off' symptoms.
Journal: Clinical neuropharmacology20070101
Title: Placebo response in Parkinson trials using patient diaries: sites do matter.
Journal: Clinical neuropharmacology20070101
Title: A perspective on adjunctive therapy for Parkinson disease with monoamine oxidase-B inhibition.
Journal: Clinical neuropharmacology20070101
Title: Neuroprotection by propargylamines in Parkinson's disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers.
Journal: Journal of neural transmission. Supplementum20070101
Title: Pharmacokinetic studies of (-)-deprenyl and some of its metabolites in mouse.
Journal: Journal of neural transmission. Supplementum20070101
Title: Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.
Journal: Psychopharmacology bulletin20070101
Title: Commentary on the treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.
Journal: Psychopharmacology bulletin20070101
Title: Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090.
Journal: HIV clinical trials20070101
Title: Simultaneous determination of selegiline and desmethylselegiline in human body fluids by headspace solid-phase microextraction and gas chromatography-mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20061205
Title: Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence.
Journal: Drug and alcohol dependence20061201
Title: Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
Journal: Journal of clinical psychopharmacology20061201
Title: L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action.
Journal: Pharmacology, biochemistry, and behavior20061201
Title: The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30.
Journal: Current Alzheimer research20061201
Title: Monoamine oxidase inhibitory coumarins from the aerial parts of Dictamnus albus.
Journal: Archives of pharmacal research20061201
Title: A new application of pre-normalized principal component analysis for improvement of image quality and clinical diagnosis in human brain PET studies--clinical brain studies using [11C]-GR205171, [11C]-L-deuterium-deprenyl, [11C]-5-Hydroxy-L-Tryptophan, [11C]-L-DOPA and Pittsburgh Compound-B.
Journal: NeuroImage20061101
Title: Therapeutic efficacy of selegiline in neurodegenerative disorders and neurological diseases.
Journal: Current drug targets20061101
Title: Acute effects of moclobemide and deprenyl on 5-HT synthesis rates in the rat brain: An autoradiographic study.
Journal: Brain research bulletin20061016
Title: Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia20061001
Title: A systematic review of research on strategies for the management of antipsychotic-induced sexual dysfunction: high-level evidence is needed.
Journal: The Journal of clinical psychiatry20061001
Title: Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases.
Journal: Parkinsonism & related disorders20060901
Title: Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.
Journal: The Journal of clinical psychiatry20060901
Title: The combined use of human neural and liver cell lines and mouse hepatocytes improves the predictability of the neurotoxicity of selected drugs.
Journal: Toxicology letters20060820
Title: Cytoprotective effect of two synthetic enhancer substances, (-)-BPAP and (-)-deprenyl, on human brain capillary endothelial cells and rat PC12 cells.
Journal: Life sciences20060808
Title: (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
Journal: European journal of pharmacology20060807
Title: Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects.
Journal: Journal of clinical pharmacology20060801
Title: Effects of subchronic treatment with selegiline on L-DOPA-induced increase in extracellular dopamine level in rat striatum.
Journal: Journal of pharmacological sciences20060801
Title: Placebo-controlled study examining effects of selegiline in children with attention-deficit/hyperactivity disorder.
Journal: Journal of child and adolescent psychopharmacology20060801
Title: A new way to deliver psychiatric meds.
Journal: Behavioral healthcare20060801
Title: Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.
Journal: The Cochrane database of systematic reviews20060719
Title: [Molecular mechanisms of the neuroprotective effect of (-)-deprenyl].
Journal: Orvosi hetilap20060709
Title: L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Journal: Neurochemistry international20060701
Title: Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain.
Journal: Neurotoxicology20060701
Title: Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl.
Journal: Neurobiology of disease20060701
Title: Transdermal selegiline: a novel MAOI formulation for depression.
Journal: Journal of psychosocial nursing and mental health services20060701
Title: Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments.
Journal: Journal of pharmacokinetics and pharmacodynamics20060601
Title: High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
Journal: Acta pharmacologica Sinica20060601
Title: Rationale for considering that propargylamines might be neuroprotective in Parkinson's disease.
Journal: Neurology20060523
Title: Transdermal selegiline (Emsam).
Journal: The Medical letter on drugs and therapeutics20060522
Title: Initial pharmacotherapy in a population of veterans with Parkinson disease.
Journal: Neurology20060509
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501
Title: Leading the way: advances in the diagnosis, treatment, and management of neuropsychiatric illnesses.
Journal: CNS spectrums20060501
Title: Transdermal selegiline: the new generation of monoamine oxidase inhibitors.
Journal: CNS spectrums20060501
Title: Why the transdermal delivery of selegiline (6 mg/24 hr) obviates the need for a dietary restriction on tyramine.
Journal: Journal of psychiatric practice20060501
Title: Amphetamine-induced locomotor activity is reduced in mice following MPTP treatment but not following selegiline/MPTP treatment.
Journal: Pharmacology, biochemistry, and behavior20060501
Title: High-performance liquid chromatographic-mass spectrometric determination of methamphetamine and amphetamine enantiomers, desmethylselegiline and selegiline, in hair samples of long-term methamphetamine abusers or selegiline users.
Journal: Journal of analytical toxicology20060501
Title: The necessity of having a proper dose of (-)deprenyl (D) to prolong the life spans of rats explains discrepancies among different studies in the past.
Journal: Annals of the New York Academy of Sciences20060501
Title: Selegiline slows the progression of the symptoms of Parkinson disease.
Journal: Neurology20060425
Title: Patient page. Slowing down a 'slow' movement disorder: selegiline's benefit in treating Parkinson disease.
Journal: Neurology20060425
Title: Metabolic transformation plays a primary role in the psychostimulant-like discriminative-stimulus effects of selegiline [(R)-(-)-deprenyl].
Journal: The Journal of pharmacology and experimental therapeutics20060401
Title: Novel transdermal delivery formulation of the monoamine oxidase inhibitor selegiline nearing release for treatment of depression.
Journal: The Journal of clinical psychiatry20060401
Title: Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
Journal: European journal of pharmacology20060227
Title: The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Journal: Journal of pharmaceutical and biomedical analysis20060224
Title: Effects of selegiline on antioxidant systems in the nigrostriatum in rat.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20060201
Title: Modulation of brain mitochondrial function by deprenyl.
Journal: Neurochemistry international20060201
Title: Clomipramine and selegiline: do they influence impulse control?
Journal: Journal of veterinary pharmacology and therapeutics20060201
Title: H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
Journal: The European journal of neuroscience20060201
Title: Novel cytoprotective mechanism of anti-parkinsonian drug deprenyl: PI3K and Nrf2-derived induction of antioxidative proteins.
Journal: Biochemical and biophysical research communications20060120
Title: Acute and delayed effect of (-) deprenyl and (-) 1-phenyl-2-propylaminopentane (PPAP) on the serotonin content of peritoneal cells (white blood cells and mast cells).
Journal: Cell biochemistry and function20060101
Title: Deprenyl and the relationship between its effects on spatial memory, oxidant stress and hippocampal neurons in aged male rats.
Journal: Physiological research20060101
Title: Chronic exposure of rats to cognition enhancing drugs produces a neuroplastic response identical to that obtained by complex environment rearing.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20060101
Title: Major depression and the synthetic enhancer substances, (-)-deprenyl and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.
Journal: Progress in neuro-psychopharmacology & biological psychiatry20060101
Title: A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys.
Journal: Psychopharmacology20060101
Title: Efficacy and safety of high-dose cabergoline in Parkinson's disease.
Journal: Acta neurologica Scandinavica20060101
Title: Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness.
Journal: British journal of pharmacology20060101
Title: Effect of nerodilol, carvone and anethole on the in vitro transdermal delivery of selegiline hydrochloride.
Journal: Die Pharmazie20060101
Title: Treatment of primary progressive freezing of gait with high doses of selegiline.
Journal: Clinical neuropharmacology20060101
Title: Persistent sexual side effects after SSRI discontinuation.
Journal: Psychotherapy and psychosomatics20060101
Title: Quality of life in Parkinson's disease--Indian scenario.
Journal: The Journal of the Association of Physicians of India20060101
Title: Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Journal: The Journal of clinical psychiatry20060101
Title: Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition.
Journal: The Journal of neuropsychiatry and clinical neurosciences20060101
Title: First depression patch approved.
Journal: FDA consumer20060101
Title: [Interaction of pyruvate kinase with isatin and deprenyl].
Journal: Biomeditsinskaia khimiia20060101
Title: Therapeutic options for cognitive decline in senior pets.
Journal: Journal of the American Animal Hospital Association20060101
Title: Selegiline induces neuronal phenotype and neurotrophins expression in embryonic stem cells.
Journal: Rejuvenation research20060101
Title: Isatin interaction with glyceraldehyde-3-phosphate dehydrogenase, a putative target of neuroprotective drugs: partial agonism with deprenyl.
Journal: Journal of neural transmission. Supplementum20060101
Title: Deprenyl: from chemical synthesis to neuroprotection.
Journal: Journal of neural transmission. Supplementum20060101
Title: Low dose (-)deprenyl is cytoprotective: it maintains mitochondrial membrane potential and eliminates oxygen radicals.
Journal: Life sciences20051205
Title: A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline.
Journal: Pharmacology, biochemistry, and behavior20051201
Title: Dementia.
Journal: Clinical evidence20051201
Title: Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons.
Journal: Brain research. Molecular brain research20051130
Title: Deprenyl enhances the striatal neuronal damage produced by quinolinic acid.
Journal: Brain research. Molecular brain research20051118
Title: Increased cell-cell adhesion, a novel effect of R-(-)-deprenyl.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20051101
Title: Role of the redox protein thioredoxin in cytoprotective mechanism evoked by (-)-deprenyl.
Journal: Molecular pharmacology20051101
Title: Selegiline protects against recognition memory impairment induced by neonatal iron treatment.
Journal: Experimental neurology20051101
Title: Harmane inhibits serotonergic dorsal raphe neurons in the rat.
Journal: Psychopharmacology20051101
Title: Parkinson's disease and sleep.
Journal: Neurologic clinics20051101
Title: Selegiline orally disintegrating tablets for the treatment of Parkinson's disease.
Journal: Expert review of neurotherapeutics20051101
Title: Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
Journal: Expert review of neurotherapeutics20051101
Title: Would caregivers of Alzheimer disease patients involve their relative in a decision to use an AD-slowing medication?
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry20051101
Title: 2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice.
Journal: Pharmacology, biochemistry, and behavior20051101
Title: Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats.
Journal: Neurochemical research20051101
Title: Discriminative stimulus and reinforcing effects of p-fluoro-L-deprenyl in monkeys.
Journal: Psychopharmacology20051001
Title: Antidepressant-like effects of selegiline in the forced swim test.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology20051001
Title: In vivo measurement of brain monoamine oxidase B occupancy by rasagiline, using (11)C-l-deprenyl and PET.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine20051001
Title: Protein aggregation in retinal cells and approaches to cell protection.
Journal: Cellular and molecular neurobiology20050901
Title: Effects of selegiline alone or with donepezil on memory impairment in rats.
Journal: European journal of pharmacology20050822
Title: LED fluorescence spectroscopy for direct determination of monoamine oxidase B inactivation.
Journal: Analytical biochemistry20050815
Title: Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease.
Journal: Journal of clinical pharmacology20050801
Title: Reexamination of the TEMPO Study.
Journal: Archives of neurology20050801
Title: Rasagiline.
Journal: Nature reviews. Drug discovery20050801
Title: Monoamine oxidase B inhibitors for early Parkinson's disease.
Journal: The Cochrane database of systematic reviews20050720
Title: Evidence for reduced arterial plasma input, prolonged lung retention and reduced lung monoamine oxidase in smokers.
Journal: Nuclear medicine and biology20050701
Title: Detection of N-monomethyl-lysine generated by metabolic transmethylation.
Journal: Analytical and bioanalytical chemistry20050601
Title: Contribution of L-3,4-dihydroxyphenylalanine metabolism to the inhibition of gluconeogenesis in rabbit kidney-cortex tubules.
Journal: The international journal of biochemistry & cell biology20050601
Title: Administration of selegiline is not associated with visual hallucinations in advanced Parkinson's disease patients.
Journal: Parkinsonism & related disorders20050601
Title: Reversal of age-related deficits in object recognition memory in rats with l-deprenyl.
Journal: Experimental gerontology20050601
Title: Parkinson's disease.
Journal: Clinical evidence20050601
Title: Parkinson's disease. Diagnosis and the initiation of therapy.
Journal: Minerva medica20050601
Title: Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Journal: Movement disorders : official journal of the Movement Disorder Society20050501
Title: [A case of interval form of carbon monoxide poisoning with a remarkable recovery].
Journal: Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics20050501
Title: Mechanism of 1-methyl-4-phenylpyridinium-induced dopamine release from PC12 cells.
Journal: Neurochemical research20050501
Title: HPLC and HPLC-MS analysis of urinary N(epsilon)-monomethyl-lysine.
Journal: Journal of chromatographic science20050401
Title: [Role of R-(-)-deprenyl in adhesion of neuronal and non-neuronal cells].
Journal: Orvosi hetilap20050327
Title: 'Levodopa phobia': a new iatrogenic cause of disability in Parkinson disease.
Journal: Neurology20050308
Title: Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
Journal: Neuroscience research20050301
Title: Therapeutic agents for the treatment of cognitive dysfunction syndrome in senior dogs.
Journal: Progress in neuro-psychopharmacology & biological psychiatry20050301
Title: Estimation of endogenous noradrenaline release in rat brain in vivo using [3H]RX 821002.
Journal: Synapse (New York, N.Y.)20050201
Title: The effects of acute loading with levodopa and levodopa with selegiline on blood pressure and plasma norepinephrine levels in chronic Parkinson's disease patients.
Journal: Acta neurologica Scandinavica20050201
Title: Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia.
Journal: The American journal of psychiatry20050201
Title: Effects of high-dose selegiline on morphine reinforcement and precipitated withdrawal in dependent rats.
Journal: Behavioural pharmacology20050201
Title: Selegiline in the management of apathy following traumatic brain injury.
Journal: Brain injury20050201
Title: Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort.
Journal: Neurology20050111
Title: Selegiline modifies the extinction of responding following morphine self-administration, but does not alter cue-induced reinstatement, reacquisition of morphine reinforcement, or precipitated withdrawal.
Journal: Pharmacological research20050101
Title: Molecular characterization of monoamine oxidase in zebrafish (Danio rerio).
Journal: Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology20050101
Title: Marked effect of liver and kidney function on the pharmacokinetics of selegiline.
Journal: Clinical pharmacology and therapeutics20050101
Title: Intracellular dopamine oxidation mediates rotenone-induced apoptosis in PC12 cells.
Journal: Acta pharmacologica Sinica20050101
Title: Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatum.
Journal: Neuroscience20050101
Title: sgk1, a member of an RNA cluster associated with cell death in a model of Parkinson's disease.
Journal: The European journal of neuroscience20050101
Title: Other pharmacological treatments for motor complications and dyskinesias.
Journal: Movement disorders : official journal of the Movement Disorder Society20050101
Title: Dislocation of the glenoid fossa.
Journal: Journal of shoulder and elbow surgery20050101
Title: 'My involvement in aging research was just a series of coincidences' An interview with Kenichi Kitani. Interview by Sataro Goto.
Journal: Biogerontology20050101
Title: Remarkable effect of selegiline (L-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case report.
Journal: Clinical neuropharmacology20050101
Title: A rapid, sensitive electron-capture gas chromatographic procedure for analysis of metabolites of N-methyl,N-propargylphenylethylamine, a potential neuroprotective agent.
Journal: Journal of pharmacological and toxicological methods20050101
Title: Effect of I-deprenyl and gliclazide on oxidant stress/antioxidant status and dna damage in a diabetic rat model.
Journal: Endocrine research20050101
Title: Dose-dependency of life span prolongation of F344/DuCrj rats injected with (-)deprenyl.
Journal: Biogerontology20050101
Title: [Alzheimer's disease therapy--theory and practice].
Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)20050101
Title: Deprenyl, a therapeutic agent for Parkinson's disease, inhibits arsenic toxicity potentiated by GSH depletion via inhibition of JNK activation.
Journal: Journal of toxicology and environmental health. Part A20041201
Title: Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson's disease.
Journal: Medical science monitor : international medical journal of experimental and clinical research20041201
Title: Treatment possibilities of Alzheimer's disease.
Journal: Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology20041201
Title: The use of the synthetic enhancer substances (-)-deprenyl and (-)-BPAP in major depression.
Journal: Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology20041201
Title: Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson's disease.
Journal: Neurology20041012
Title: A novel formulation of selegiline for the treatment of Parkinson's disease.
Journal: Neurology20041012
Title: Clinical trials of neuroprotection for Parkinson's disease.
Journal: Neurology20041012
Title: A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's disease.
Journal: Neurology20041012
Title: Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline.
Journal: British journal of pharmacology20041001
Title: Levodopa-responsive parkinsonism in hereditary spastic paraplegia with thin corpus callosum.
Journal: Parkinsonism & related disorders20041001
Title: In vitro confirmation of selegiline N-oxidation by flavin-containing monooxygenase in rat microsome using LC-ESI MS.
Journal: Biological & pharmaceutical bulletin20041001
Title: Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.
Journal: European journal of pharmacology20040919
Title: Pitfalls of animal model systems in ageing research.
Journal: Best practice & research. Clinical endocrinology & metabolism20040901
Title: Effects of repeated administration of Uncaria hooks on the acquisition and central neuronal activities in ethanol-treated mice.
Journal: Journal of ethnopharmacology20040901
Title: (-)-Deprenyl alleviates the degenerative changes induced in the neonatal rat spinal cord by CSF from amyotrophic lateral sclerosis patients.
Journal: Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases20040901
Title: High-performance liquid chromatography/tandem mass spectrometry assay for the determination of 1-methyl-4-phenyl pyridinium (MPP+) in brain tissue homogenates.
Journal: Journal of neuroscience methods20040830
Title: 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotonin-reuptake transporter, and monoamine oxidase-B.
Journal: Neuroscience letters20040826
Title: Subthalamic deep brain stimulation masking possible malignant syndrome in Parkinson disease.
Journal: Neurology20040810
Title: Pharmacological aspects of (-)-deprenyl.
Journal: Current medicinal chemistry20040801
Title: Assessment of the N-oxidation of deprenyl, methamphetamine, and amphetamine enantiomers by chiral capillary electrophoresis: an in vitro metabolism study.
Journal: Electrophoresis20040801
Title: Selectivity of 7-alkoxycoumarins as probe substrates for rat hepatic cytochrome P450 forms is influenced by the substitution pattern on the coumarin nucleus.
Journal: Xenobiotica; the fate of foreign compounds in biological systems20040801
Title: Selegiline potentiates the effects of EGb 761 in response to ischemic brain injury.
Journal: Neurochemistry international20040701
Title: Selegiline, an MAO-B inhibitor, attenuates airway smooth muscle contraction in the rat trachea.
Journal: The Journal of pharmacy and pharmacology20040701
Title: Selegiline increases heme oxygenase-1 expression and the cytotoxicity produced by dopamine treatment of neuroblastoma SK-N-SH cells.
Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas20040701
Title: Modulation of glucose uptake in glial and neuronal cell lines by selected neurological drugs.
Journal: Toxicology letters20040615
Title: Therapeutic factors causing hallucination in Parkinson's disease patients, especially those given selegiline.
Journal: Parkinsonism & related disorders20040601
Title: Dementia.
Journal: Clinical evidence20040601
Title: Parkinson's disease.
Journal: Clinical evidence20040601
Title: 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells.
Journal: Journal of neuroscience research20040515
Title: Pharmacological studies with endogenous enhancer substances: beta-phenylethylamine, tryptamine, and their synthetic derivatives.
Journal: Progress in neuro-psychopharmacology & biological psychiatry20040501
Title: Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells.
Journal: Investigative ophthalmology & visual science20040501
Title: A 'cure' for Parkinson's disease: can neuroprotection be proven with current trial designs?
Journal: Movement disorders : official journal of the Movement Disorder Society20040501
Title: Inefficacy of selegiline in treatment of canine pituitary-dependent hyperadrenocorticism.
Journal: Australian veterinary journal20040501
Title: Comparison of the binding of the irreversible monoamine oxidase tracers, [(11)C]clorgyline and [(11)C]l-deprenyl in brain and peripheral organs in humans.
Journal: Nuclear medicine and biology20040401
Title: Cardiopulmonary effects of medetomidine, oxymorphone, or butorphanol in selegiline-treated dogs.
Journal: Veterinary anaesthesia and analgesia20040401
Title: Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled study.
Journal: Movement disorders : official journal of the Movement Disorder Society20040401
Title: Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs.
Journal: Acta neuropathologica20040301
Title: (-)-Deprenyl inhibits tyramine-induced noradrenaline release, but not tyramine-induced dopamine release or potassium-induced noradrenaline release, from rat brain synaptosomes.
Journal: Pharmacological research20040301
Title: Transdermal selegiline and intravenous cocaine: safety and interactions.
Journal: Psychopharmacology20040201
Title: l-Deprenyl prevents lipid peroxidation and memory deficits produced by cerebral ischemia in rats.
Journal: Cellular and molecular neurobiology20040201
Title: Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline.
Journal: Neuroscience letters20040130
Title: Positive effects of deprenyl and estradiol on spatial memory and oxidant stress in aged female rat brains.
Journal: Neuroscience letters20040116
Title: Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus.
Journal: Neurotoxicology20040101
Title: (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
Journal: Neurotoxicology20040101
Title: Adverse effects of dopamine potentiation by long-term treatment with selegiline.
Journal: Movement disorders : official journal of the Movement Disorder Society20040101
Title: Chiral separation of deprenyl-N-oxide isomers by capillary electrophoresis using various cyclodextrin derivatives.
Journal: Journal of chromatographic science20040101
Title: [Prognosis in Alzheimer's disease].
Journal: Nihon rinsho. Japanese journal of clinical medicine20040101
Title: Effects of the DT-diaphorase inhibitor dicumarol on striatal monoamine levels in L-DOPA and L-deprenyl pre-treated rats.
Journal: Neurotoxicity research20040101
Title: Brain cholinesterases: III. Future perspectives of AD research and clinical practice.
Journal: Medical hypotheses20040101
Title: Effects of dopaminergic treatment on bladder function in Parkinson's disease.
Journal: Neurourology and urodynamics20040101
Title: In vitro formation of selegiline-N-oxide as a metabolite of selegiline in human, hamster, mouse, rat, guinea-pig, rabbit and dog.
Journal: European journal of drug metabolism and pharmacokinetics20040101
Title: [The effect of long-term administration of isatin and himantan to mice on sensitivity of brain monoamine oxidase B to inhibition by deprenyl in vivo and in vitro].
Journal: Biomeditsinskaia khimiia20040101
Title: Selegiline in comparison with methylphenidate in attention deficit hyperactivity disorder children and adolescents in a double-blind, randomized clinical trial.
Journal: Journal of child and adolescent psychopharmacology20040101
Title: Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20031201
Title: Analysis of benzene ethylamine derivatives in urine using the programmable dynamic liquid-phase microextraction (LPME) device.
Journal: The Analyst20031201
Title: The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
Journal: Annals of the New York Academy of Sciences20031201
Title: Relationship between imidazoline(2) sites and monoamine oxidase.
Journal: Annals of the New York Academy of Sciences20031201
Title: Pro-apoptotic and anti-apoptotic molecules affecting pathways of signal transduction.
Journal: Annals of the New York Academy of Sciences20031201
Title: Parkinson's disease.
Journal: Clinical evidence20031201
Title: Reduced cardiovascular effects of methamphetamine following treatment with selegiline.
Journal: Drug and alcohol dependence20031124
Title: Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity.
Journal: British journal of cancer20031117
Title: Transdermal selegiline: targeted effects on monoamine oxidases in the brain.
Journal: Biological psychiatry20031115
Title: L-Deprenyl as an inhibitor of menadione-induced permeability transition in liver mitochondria.
Journal: Biochemical pharmacology20031101
Title: Clinical inquiries. What is the best initial treatment of Parkinson's disease?
Journal: The Journal of family practice20031101
Title: Selegiline reduces N-methyl-D-aspartic acid induced perturbation of neurotransmission but it leaves NMDA receptor dependent long-term potentiation intact in the hippocampus.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20031101
Title: A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20031101
Title: A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20031101
Title: Selegiline's neuroprotective capacity revisited.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20031101
Title: L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.
Journal: Neurology20031014
Title: D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Journal: Synapse (New York, N.Y.)20031001
Title: A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation.
Journal: Addiction (Abingdon, England)20031001
Title: Pharmacologic treatment of Alzheimer's disease: an update.
Journal: American family physician20031001
Title: Sublingual selegiline: new formulation. New formulation: new risk of oral adverse effects.
Journal: Prescrire international20031001
Title: L-selegiline potentiates the cellular poly(ADP-ribosyl)ation response to ionizing radiation.
Journal: The Journal of pharmacology and experimental therapeutics20030901
Title: Selegiline long-term effects on brain acetylcholinesterase, (Na+,K+)-ATPase activities, antioxidant status and learning performance of aged rats.
Journal: Pharmacological research20030901
Title: Cytochrome P450-dependent metabolism of l-deprenyl in monkey (Cercopithecus aethiops) and C57BL/6 mouse brain microsomal preparations.
Journal: Journal of neurochemistry20030901
Title: Comparative studies on the cytochrome p450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems.
Journal: Drug metabolism and disposition: the biological fate of chemicals20030901
Title: Deprenyl blocks the aglycemia-induced depression of the synaptic transmission but not the ischemia-induced depression in neonatal rat spinal cord in vitro.
Journal: Neuroscience research20030901
Title: Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.
Journal: Neurology20030812
Title: [Therapy for patients with early-stage Parkinson's disease].
Journal: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine20030810
Title: Enhancer regulation/endogenous and synthetic enhancer compounds: a neurochemical concept of the innate and acquired drives.
Journal: Neurochemical research20030801
Title: Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture.
Journal: Neuroscience research20030801
Title: Effects of monoamine oxidase inhibitors on the diethyldithiocarbamate-induced enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in C57BL/6 mice.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20030801
Title: Recovery of motor function and dopaminergic parameters in a mouse model of Parkinson's disease induced by co-administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20030801
Title: Chiral characterization of deprenyl-N-oxide and other deprenyl metabolites by capillary electrophoresis using a dual cyclodextrin system in rat urine.
Journal: Electrophoresis20030801
Title: Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.
Journal: Progress in neuro-psychopharmacology & biological psychiatry20030801
Title: Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats.
Journal: Brain research20030627
Title: Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
Journal: Antioxidants & redox signaling20030601
Title: An HPLC tracing of the enhancer regulation in selected discrete brain areas of food-deprived rats.
Journal: Life sciences20030509
Title: Enhancer substances: selegiline and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes.
Journal: Life sciences20030502
Title: Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20030501
Title: Environmental influence on recovery after brain lesions--experimental and clinical data.
Journal: Journal of rehabilitation medicine20030501
Title: Neuroprotective actions of Selegiline in inhibiting 1-methyl, 4-phenyl, pyridinium ion (MPP+)-induced apoptosis in SK-N-SH neurons.
Journal: Journal of neurocytology20030501
Title: A pharmacological analysis elucidating why, in contrast to (-)-deprenyl (selegiline), alpha-tocopherol was ineffective in the DATATOP study.
Journal: Life sciences20030425
Title: Selegiline potentiates cocaine-induced increases in rodent nucleus accumbens dopamine.
Journal: Synapse (New York, N.Y.)20030401
Title: Quantitative analysis of desmethylselegiline, methamphetamine, and amphetamine in hair and plasma from Parkinson patients on long-term selegiline medication.
Journal: Journal of analytical toxicology20030401
Title: Selegiline in the treatment of Parkinson's disease: its impact on orthostatic hypotension.
Journal: Parkinsonism & related disorders20030301
Title: Safety of selegiline with cold medications.
Journal: The Annals of pharmacotherapy20030301
Title: [Biomedical imaging in pharmacology with nuclear medical imaging methodologies: positron emission tomography (PET) and single photon emission computed tomography (SPECT)].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica20030301
Title: Monoamine oxidase inhibitors--is it time to up the TEMPO?
Journal: The Lancet. Neurology20030301
Title: Selegiline attenuates cardiac oxidative stress and apoptosis in heart failure: association with improvement of cardiac function.
Journal: European journal of pharmacology20030214
Title: l-Deprenyl metabolism by the cytochrome P450 system in monkey (Cercopithecus aethiops) liver microsomes.
Journal: Xenobiotica; the fate of foreign compounds in biological systems20030201
Title: A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder.
Journal: The Journal of clinical psychiatry20030201
Title: The relevance of preclinical studies for the treatment of Parkinson's disease.
Journal: Journal of neurology20030201
Title: A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation.
Journal: Biological psychiatry20030115
Title: Protective effects of selegiline and desmethylselegiline against N-methyl-D-aspartate-induced rat retinal damage.
Journal: European journal of pharmacology20030101
Title: Evidence for dopamine-derived hydroxyl radical formation in the nigrostriatal system in response to axotomy.
Journal: Free radical biology & medicine20030101
Title: Selegiline for Alzheimer's disease.
Journal: The Cochrane database of systematic reviews20030101
Title: In vivo imaging of brain dopaminergic neurotransmission system in small animals with high-resolution single photon emission computed tomography.
Journal: Analytical sciences : the international journal of the Japan Society for Analytical Chemistry20030101
Title: Selegiline-transdermal--Somerset: Emsam.
Journal: Drugs in R&D20030101
Title: Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion.
Journal: Neurobiology of aging20030101
Title: Daily transdermal administration of selegiline to guinea-pigs preferentially inhibits monoamine oxidase activity in brain when compared with intestinal and hepatic tissues.
Journal: The Journal of pharmacy and pharmacology20030101
Title: Neuroprotection for Parkinson's disease: prospects and promises.
Journal: Annals of neurology20030101
Title: Lack of influence of the apolipoprotein E genotype on the outcome of selegiline treatment in Alzheimer's disease.
Journal: Dementia and geriatric cognitive disorders20030101
Title: Neurostimulatory and antioxidative effects of L-deprenyl in aged rat brain regions.
Journal: Biogerontology20030101
Title: Clinical pharmacokinetics of cabergoline.
Journal: Clinical pharmacokinetics20030101
Title: Selegiline in the treatment of sexual dysfunction in schizophrenic patients maintained on neuroleptics: a pilot study.
Journal: Clinical neuropharmacology20030101
Title: Noncholinergic treatment options for Alzheimer's disease.
Journal: The Journal of clinical psychiatry20030101
Title: Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's disease.
Journal: Journal of neural transmission. Supplementum20030101
Title: Antioxidant properties of newly synthesized N-propargylamine derivatives of nitroxyl: a comparison with deprenyl.
Journal: Polish journal of pharmacology20030101
Title: Neuroprotective effect of deprenyl in sensory neurons of axotomized dorsal root ganglion.
Journal: Clinical neuropharmacology20030101
Title: [Mild cognitive impairment].
Journal: Ryoikibetsu shokogun shirizu20030101
Title: [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity].
Journal: Eksperimental'naia i klinicheskaia farmakologiia20030101
Title: Medical treatment of hyperadrenocorticism in the dog.
Journal: Australian veterinary journal20030101
Title: Detection, quantification, metabolism, and behavioral effects of selegiline in horses.
Journal: Veterinary therapeutics : research in applied veterinary medicine20030101
Title: Selegiline enhances erectile activity induced by dopamine injection in the paraventricular nucleus of the hypothalamus in anesthetized rats.
Journal: International journal of impotence research20021201
Title: [Long-term treatment of Parkinson's disease patients with selegiline hydrochloride (FPF 1100): outcome of 5-year treatment].
Journal: No to shinkei = Brain and nerve20021201
Title: Recent advances in Parkinson's disease.
Journal: Ideggyogyaszati szemle20021120
Title: Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients.
Journal: The American journal of psychiatry20021101
Title: Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
Journal: Neuropharmacology20021101
Title: Effects of short- and long-term (--)-deprenyl administration on mRNA for copper, zinc- and manganese-superoxide dismutase and glutathione peroxidase in rat brain.
Journal: Brain research20021025
Title: PET imaging of monoamine oxidase B in peripheral organs in humans.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine20021001
Title: Quantitative analysis of selegiline and three metabolites (N-desmethylselegiline, methamphetamine, and amphetamine) in human plasma by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
Journal: Journal of analytical toxicology20021001
Title: Practical importance of neuroprotection in Parkinson's disease.
Journal: Journal of neurology20021001
Title: 1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (-)-BPAP in the shuttle box and leaves the effect of (-)-deprenyl unchanged.
Journal: Life sciences20020913
Title: Effects of selegiline (L-deprenyl) during smoking and short-term abstinence.
Journal: Psychopharmacology20020901
Title: Urinary excretion of selegiline N-oxide, a new indicator for selegiline administration in man.
Journal: Xenobiotica; the fate of foreign compounds in biological systems20020901
Title: Selegiline: a second look. Six years later: too risky in Parkinson's disease.
Journal: Prescrire international20020801
Title: Selegiline transdermal system Somerset.
Journal: Current opinion in investigational drugs (London, England : 2000)20020801
Title: Effects of (-)deprenyl (selegiline) on acetylcholinesterase and Na(+),K(+)-ATPase activities in adult rat whole brain.
Journal: Pharmacological research20020801
Title: Treatment of an acromegalic cat with the dopamine agonist L-deprenyl.
Journal: Australian veterinary journal20020801
Title: [The usefulness of dopaminergic drugs in traumatic brain injury].
Journal: Revista de neurologia20020801
Title: Neurological effects of psychopharmacological agents.
Journal: Seminars in clinical neuropsychiatry20020701
Title: Effect of concomitant hormone replacement therapy containing estradiol and levonorgestrel on the pharmacokinetics of selegiline.
Journal: European journal of clinical pharmacology20020701
Title: Smoking cessation and panic attacks: a report of 2 cases.
Journal: The Journal of clinical psychiatry20020701
Title: Electroencephalographic activation by tacrine, deprenyl, and quipazine: cholinergic vs. non-cholinergic contributions.
Journal: European journal of pharmacology20020628
Title: Effects of selegiline, phenylpropanolamine, or a combination of both on physiologic and behavioral variables in healthy dogs.
Journal: American journal of veterinary research20020601
Title: Precursor medications as a source of methamphetamine and/or amphetamine positive drug testing results.
Journal: Journal of occupational and environmental medicine20020501
Title: (-)-Deprenyl fails to promote axonal regeneration of retinal ganglion cells in vitro and in vivo.
Journal: Cell and tissue research20020501
Title: The effect of deprenyl washout in patients with long-standing Parkinson's disease.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20020501
Title: Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.
Journal: Annals of neurology20020501
Title: Modulation of neuroendocrine--immune signaling by L-deprenyl and L-desmethyldeprenyl in aging and mammary cancer.
Journal: Mechanisms of ageing and development20020430
Title: Why (--)deprenyl prolongs survivals of experimental animals: increase of anti-oxidant enzymes in brain and other body tissues as well as mobilization of various humoral factors may lead to systemic anti-aging effects.
Journal: Mechanisms of ageing and development20020430
Title: Pharmacological interventions in aging and age-associated disorders: potentials of propargylamines for human use.
Journal: Annals of the New York Academy of Sciences20020401
Title: Effects of selegiline on fronto-temporal dementia: a neuropsychological evaluation.
Journal: International journal of geriatric psychiatry20020401
Title: [Serotonin syndrome: report of a fatal case and review of the literature].
Journal: Revista clinica espanola20020401
Title: [The evolution of use of anti-Parkinson drugs in Spain].
Journal: Revista de neurologia20020401
Title: Inhibition of human LDL oxidation by the neuroprotective drug l-deprenyl.
Journal: Neurological research20020301
Title: Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society20020301
Title: Treatment of periodic limb movements in sleep with selegiline HCl.
Journal: Movement disorders : official journal of the Movement Disorder Society20020301
Title: Effect of R-(-)-deprenyl and harmaline on dopamine- and peroxynitrite-induced membrane permeability transition in brain mitochondria.
Journal: Neurochemical research20020301
Title: Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease.
Journal: Parkinsonism & related disorders20020301
Title: Neuroprotective actions of selegiline.
Journal: Journal of neuroscience research20020201
Title: The effect of selegiline in the treatment of people with Alzheimer's disease: a meta-analysis of published trials.
Journal: International journal of geriatric psychiatry20020201
Title: Antiapoptotic effect of (-)-deprenyl in rat kidney after ischemia-reperfusion.
Journal: Medical science monitor : international medical journal of experimental and clinical research20020201
Title: Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum.
Journal: Toxicology20020125
Title: The influence of metabolism on the MAO-B inhibitory potency of selegiline.
Journal: Current medicinal chemistry20020101
Title: Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels.
Journal: Naunyn-Schmiedeberg's archives of pharmacology20020101
Title: Nitecapone and selegiline as effective adjuncts to L-DOPA in reserpine-induced catatonia in mice.
Journal: Methods and findings in experimental and clinical pharmacology20020101
Title: Morphometric evaluation of the neuroprotective effect of deprenyl on postaxotomic motor neuron losses.
Journal: Clinical neuropharmacology20020101
Title: [Study of the tissue and subcellular distribution of isatin-binding proteins with optical biosensor].
Journal: Voprosy meditsinskoi khimii20020101
Title: Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline.
Journal: Clinical neuropharmacology20020101
Title: MAO-B inhibitors for the treatment of Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society20020101
Title: [Monoamine oxidase inhibitors: prospects for the use in clinical practice].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova20020101
Title: The multiple actions of selegiline.
Journal: Proceedings of the Western Pharmacology Society20020101
Title: Monoamine oxidase inhibitors: a new generation.
Journal: Psychopharmacology bulletin20020101
Title: Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.
Journal: The Cochrane database of systematic reviews20020101
Title: [Effectiveness and tolerability of selegiline in the treatment of pathological cerebral involutions].
Journal: La Clinica terapeutica20020101
Title: Zonisamide has beneficial effects on Parkinson's disease patients.
Journal: Neuroscience research20011201
Title: Investigating potential anxiolytic, antidepressant and memory enhancing activity of deprenyl.
Journal: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society20011201
Title: Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial.
Journal: Neurology20011113
Title: Chronic daily administration of selegiline and EGb 761 increases brain's resistance to ischemia in mice.
Journal: Brain research20011102
Title: (-)-D-Deprenyl attenuates apoptosis in experimental brain ischaemia.
Journal: European journal of pharmacology20011102
Title: CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes.
Journal: Drug metabolism and disposition: the biological fate of chemicals20011101
Title: The effects of oral selegiline hydrochloride on learning and training in the dog: a psychobiological interpretation.
Journal: Progress in neuro-psychopharmacology & biological psychiatry20011101
Title: Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release.
Journal: Pharmacology & toxicology20011101
Title: Future of neuroprotection in Parkinson's disease.
Journal: Parkinsonism & related disorders20011001
Title: Incorporation of selegiline metabolites into hair after oral selegiline intake.
Journal: Journal of analytical toxicology20011001
Title: Medical treatment of canine pituitary-dependent hyperadrenocorticism (Cushing's disease).
Journal: The Veterinary clinics of North America. Small animal practice20010901
Title: Simultaneous determination of selegiline-N-oxide, a new indicator for selegiline administration, and other metabolites in urine by high-performance liquid chromatography-electrospray ionization mass spectrometry.
Journal: Journal of chromatography. B, Biomedical sciences and applications20010805
Title: Inhibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine.
Journal: Drug metabolism and disposition: the biological fate of chemicals20010801
Title: [Parkinson's disease].
Journal: Nihon rinsho. Japanese journal of clinical medicine20010801
Title: Changes in vascular alpha 1- and alpha 2-adrenoceptor responsiveness by selegiline treatment.
Journal: Fundamental & clinical pharmacology20010801
Title: Selegiline and mortality in subjects with Parkinson's disease: a longitudinal community study.
Journal: Neurology20010724
Title: Selegiline and mortality in subjects with Parkinson's disease: a longitudinal community study.
Journal: Neurology20010724
Title: Current advances in Parkinson's disease.
Journal: Trends in neurosciences20010701
Title: Freezing of gait in PD: prospective assessment in the DATATOP cohort.
Journal: Neurology20010626
Title: Oxygen inhalation enhances striatal dopamine metabolism and monoamineoxidase enzyme inhibition prevents it: a microdialysis study.
Journal: European journal of pharmacology20010622
Title: Advances in managing Parkinson's disease.
Journal: Hospital practice (1995)20010615
Title: PET with 11C-deuterium-deprenyl and 18F-FDG in focal epilepsy.
Journal: Acta neurologica Scandinavica20010601
Title: The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome.
Journal: Neurobiology of disease20010601
Title: Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
Journal: Pharmacology & toxicology20010601
Title: Rescue of dying neurons by (R)-deprenyl in the MPTP-mouse model of Parkinson's disease does not include restoration of neostriatal dopamine.
Journal: Annals of the New York Academy of Sciences20010601
Title: Paroxysmal hypertensive crises induced by selegiline in a patient with Parkinson's disease.
Journal: Journal of neurology20010601
Title: [Parkinson patients. Normal life expectancy with selegiline?].
Journal: MMW Fortschritte der Medizin20010528
Title: Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brain.
Journal: Life sciences20010504
Title: Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.
Journal: Bioorganic & medicinal chemistry20010501
Title: CYP2C19 polymorphism is not important for the in vivo metabolism of selegiline.
Journal: European journal of clinical pharmacology20010501
Title: Monoamine oxidase assays.
Journal: Current protocols in pharmacology20010501
Title: L-Deprenyl prevents the cell hypoxia induced by dopaminergic neurotoxins, MPP(+) and beta-carbolinium: a microdialysis study in rats.
Journal: Neuroscience letters20010420
Title: Selective inhibition of MAO-B through chronic low-dose (R)-deprenyl treatment in C57BL/6 mice has no effect on basal neostriatal dopamine levels.
Journal: Experimental neurology20010401
Title: Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-deprenyl in vivo.
Journal: Toxicology and applied pharmacology20010401
Title: Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole.
Journal: European journal of clinical pharmacology20010401
Title: Deprenyl stimulates the efflux of monoamines from the rat hypothalamus in vitro.
Journal: Brain research bulletin20010401
Title: Do antioxidant strategies work against aging and age-associated disorders? Propargylamines: a possible antioxidant strategy.
Journal: Annals of the New York Academy of Sciences20010401
Title: Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid.
Journal: The Journal of biological chemistry20010330
Title: L-dopa and selegiline for tyrosine hydroxylase deficiency.
Journal: The Journal of pediatrics20010301
Title: Parkinson's disease therapy: treatment of early and late disease.
Journal: Chinese medical journal20010301
Title: Eldepryl prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral neuronal apoptosis in mice.
Journal: Chinese medical journal20010301
Title: SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
Journal: Brain research20010223
Title: Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice.
Journal: European journal of pharmacology20010209
Title: Selegiline combined with enriched-environment housing attenuates spatial learning deficits following focal cerebral ischemia in rats.
Journal: Experimental neurology20010201
Title: The economic consequences of a drug-drug interaction.
Journal: Journal of clinical psychopharmacology20010201
Title: Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs.
Journal: Acta neuropathologica20010201
Title: Possible applications for dopaminergic agents following traumatic brain injury: part 2.
Journal: The Journal of head trauma rehabilitation20010201
Title: Selegiline completely restores choline acetyltransferase activity deficits in simian immunodeficiency infection.
Journal: European journal of pharmacology20010105
Title: Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
Journal: Medical science monitor : international medical journal of experimental and clinical research20010101
Title: Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20010101
Title: Freezing of gait in patients with advanced Parkinson's disease.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20010101
Title: Long-term persistence of symptomatic effect of selegiline in Parkinson's disease. A two-months placebo-controlled withdrawal study.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20010101
Title: Biphasic effects of selegiline on striatal dopamine: lack of effect on methamphetamine-induced dopamine depletion.
Journal: Neurochemical research20010101
Title: [Current strategies of pathogenetic therapy of Alzheimer's disease].
Journal: Vestnik Rossiiskoi akademii meditsinskikh nauk20010101
Title: Effect of longevity treatment with (-)deprenyl on lifespan and sexual behavior in female rats.
Journal: Neurobiology (Budapest, Hungary)20010101
Title: Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brain.
Journal: CNS drug reviews20010101
Title: Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20010101
Title: [The effect of selegiline and vitamin E in the treatment of ALS: an open randomized clinical trials].
Journal: Neurologia i neurochirurgia polska20010101
Title: The effect of low oral doses of (-)-deprenyl and its metabolites on DSP-4 toxicity.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20010101
Title: Pharmacological options for the treatment of Tourette's disorder.
Journal: Drugs20010101
Title: Selegiline treatment facilitates recovery after stroke.
Journal: Neurorehabilitation and neural repair20010101
Title: A noncomparative open-label study evaluating the effect of selegiline hydrochloride in a clinical setting.
Journal: Veterinary therapeutics : research in applied veterinary medicine20010101
Title: [Dopaminergic agonists in the treatment of Parkinson's disease].
Journal: Revue medicale de Bruxelles20001201
Title: Antioxidant activity of the monoamine oxidase B inhibitor lazabemide.
Journal: Biochemical pharmacology20000901
Title: A hypertensive reaction induced by concurrent use of selegiline and dopamine.
Journal: The Annals of pharmacotherapy20000901
Title: Adverse drug reactions to selegiline: a review of the French pharmacovigilance database.
Journal: Clinical neuropharmacology20000101
Title: The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning in 6-hydroxydopamine lesioned rats.
Journal: Journal of neural transmission (Vienna, Austria : 1996)20000101
Title: Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine.
Journal: European psychiatry : the journal of the Association of European Psychiatrists19991001
Title: Effect of selegiline on cognitive functions in Parkinson's disease.
Journal: The Journal of the Association of Physicians of India19990801
Title: Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology19990601
Title: Selegiline-induced postural hypotension in Parkinson's disease: a longitudinal study on the effects of drug withdrawal.
Journal: Movement disorders : official journal of the Movement Disorder Society19990301
Title: Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).
Journal: Journal of neural transmission. Supplementum19980101
Title: Experience with tranylcypromine in early Parkinson's disease.
Journal: Journal of neural transmission. Supplementum19980101
Title: Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease.
Journal: Journal of neurology, neurosurgery, and psychiatry19970801
Title: The anticonvulsant effect of deprenyl on pentylenetetrazol-induced seizures in Lewis rats.
Journal: The International journal of neuroscience19970801
Title: Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.
Journal: Journal of clinical psychopharmacology19970201
Title: Absence of acute cocaine interactions with the MAO-B inhibitor selegiline.
Journal: Drug and alcohol dependence19950701
Title: Pharmacokinetic aspects of l-deprenyl (selegiline) and its metabolites.
Journal: Clinical pharmacology and therapeutics19941201
Title: The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine.
Journal: Brain research19940711
Title: Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327.
Journal: Neurology19931001
Title: End-of-dose dystonia in Parkinson's disease.
Journal: Neurology19931001
Title: Deprenyl in attention deficit associated with Tourette's syndrome.
Journal: Archives of neurology19930301
Title: Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegiline.
Journal: Lancet (London, England)19930227
Title: Selegiline and manic behavior in Parkinson's disease.
Journal: Archives of neurology19921201
Title: In vivo and in vitro pharmacologic profile of two new irreversible MAO-B inhibitors: MDL 72,974A and fluorodeprenyl.
Journal: Annals of the New York Academy of Sciences19920511
Title: Deprenyl effects on levodopa pharmacodynamics, mood, and free radical scavenging.
Journal: Neurology19920301
Title: Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons.
Journal: The Journal of pharmacology and experimental therapeutics19911101
Title: Improvement of cognitive function by MAO-B inhibitor L-deprenyl in aged rats.
Journal: Pharmacology, biochemistry, and behavior19910601
Title: A review of the pharmacology of selegiline.
Journal: Acta neurologica Scandinavica. Supplementum19910101
Title: Evaluation of the effects of inhibition of monoamine oxidase and senescence on methamphetamine-induced neuronal damage.
Journal: International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience19910101
Title: Ro 19-6327, a reversible and highly selective monoamine, oxidase B inhibitor: a novel tool to explore the MAO-B function in humans.
Journal: Advances in neurology19900101
Title: The effect of deprenyl (selegiline) on the natural history of Parkinson's disease.
Journal: Science (New York, N.Y.)19890804
Title: A possible L-deprenyl induced hypertensive reaction.
Journal: Journal of clinical psychopharmacology19890801
Title: Potentiation of central effects of L-dopa by an inhibitor of catechol-O-methyltransferase.
Journal: Journal of neural transmission19870101
Title: SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Journal: The Journal of pharmacology and experimental therapeutics19870101
Title: Pharmacokinetic aspects of deprenyl effects.
Journal: Polish journal of pharmacology and pharmacy19840101
Title: Brain monoamine oxidase in suckling rabbits treated with organophosphorus compound. I. Acute intoxication.
Journal: Acta physiologica Polonica19840101
Title: Deprenyl (selegiline) in combination treatment of Parkinson's disease.
Journal: Acta neurologica Scandinavica. Supplementum19830101
Title: The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
Journal: Biochemical pharmacology19821115
Title: Inhibition of rabbit liver monoamine oxidase by nitro aromatic compounds.
Journal: Biochemical pharmacology19820815
Title: Oscillations in performance in levodopa-treated parkinsonians: treatment with bromocriptine and L-deprenyl.
Journal: Clinical and experimental neurology19790101
